HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of In-Stent Restenosis in Patients with Renal Artery Stenosis.

AbstractPURPOSE:
To determine clinical outcomes of patients treated for renal artery in-stent restenosis (ISR) with atherosclerotic renal artery stenosis.
MATERIALS AND METHODS:
A retrospective review was performed of the clinical data of all patients who underwent renal artery stent placement for atherosclerotic renal artery stenosis from 1996 to 2009. Medical records of patients were reviewed for relevant clinical history, including blood pressure, antihypertensive medications, and renal function data before and after an intervention. In 1,052 patients, 1,090 renal artery stent placements were performed. Of these, 101 stents in 79 patients developed ISR, which was treated with either percutaneous transluminal angioplasty (PTA) or repeat stent placement. Procedural details, including modality of intervention, stent diameter, and time to restenosis, were recorded. Hypertensive agent and use of statins were recorded. Univariate analysis was performed to identify risk factors associated with restenosis after treatment of ISR.
RESULTS:
Patients treated with repeat stent placement were 6.89 times more likely to lose patency after treatment than patients treated with PTA (P < .01). No additional clinical or procedural factor, including smoking history; presence of cardiac, renal, or metabolic disease; use of statin at time of ISR treatment; or diameter of treatment (stent or PTA), had a significant association with duration of stent or angioplasty patency.
CONCLUSIONS:
Treatment of renal artery ISR with PTA among patients with atherosclerotic renal artery stenosis has a lower rate of subsequent ISR compared with repeat stent placement.
AuthorsEdwin A Takahashi, Michael A McKusick, Haraldur Bjarnason, Ameet Piryani, William S Harmsen, Sanjay Misra
JournalJournal of vascular and interventional radiology : JVIR (J Vasc Interv Radiol) Vol. 27 Issue 11 Pg. 1657-1662 (Nov 2016) ISSN: 1535-7732 [Electronic] United States
PMID27503035 (Publication Type: Comparative Study, Journal Article)
CopyrightCopyright © 2016 SIR. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Metals
Topics
  • Aged
  • Aged, 80 and over
  • Angioplasty, Balloon (adverse effects)
  • Atherosclerosis (diagnostic imaging, physiopathology, therapy)
  • Endovascular Procedures (adverse effects, instrumentation)
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Metals
  • Middle Aged
  • Proportional Hazards Models
  • Prosthesis Design
  • Recurrence
  • Renal Artery Obstruction (diagnostic imaging, physiopathology, therapy)
  • Retreatment
  • Retrospective Studies
  • Risk Factors
  • Stents
  • Treatment Outcome
  • Vascular Patency

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: